US Overdose Deaths Reach New Record As Fentanyl/Meth Use Soars Drug overdose deaths reached another record last year, peaking at just under...
The IMF/World Bank Spring Meetings are a time when financing for sustainable development gets attention. This year, it was apparent that the main channels...
The U.S. Food and Drug Administration (FDA) has given approval for the commercialization of Eli Lilly and Company and Incyte’s Olumiant (baricitinib),...
The Institute for Clinical and Economic Review recommended two out of three outpatient treatments for COVID-19 in the market today, singling out molnupiravir...
Explainer: Some patients reporting COVID rebounds after taking Pfizer pills May 11, 2022, 7:23 AM EDT By Michael Erman May 11 (Reuters) – More than 2.8...
Joseph Kim, the longtime CEO who’s become almost synonymous with Inovio, is leaving the beleaguered company. Jacqueline Shea Stepping down to make room...
Antimicrobial resistance is a growing problem and one that is already claiming over a million lives per year. The post The antimicrobial pipeline is ‘dry’...
The Institute for Clinical and Economic Review, a pharma drug pricing watchdog, recently dug into the data on three Covid-19 therapeutics, voting 11-2...
Less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication, researchers...
Not content with a $1.2 billion licensing deal for Biohaven Pharma’s oral migraine therapy rimegepant, Pfizer has just The post Pfizer upgrades Biohaven...
Ribonucleic acids (RNAs), which decode the genetic code stored in DNA and produce proteins, fold into diverse structures to govern fundamental biological...
Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC), The post Saving lives...
Despite the effectiveness of vaccination campaigns worldwide, the threat posed by Covid-19 still exists. First of all, a new SARS-CoV-2 variant could very...
Patients diagnosed with cancer more than a year before contracting COVID-19 and those not receiving active treatment may be no more vulnerable to worse...
BioNTech continues to build on the success of the company's mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline...
Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine...
Could these health care stocks be the remedy to investors’ recent stock market pains? The post Best Stocks To Buy Now? 5 Health Care Stocks In...
Uncharacterised and so far rare cases of unexplained severe liver inflammation among young children. These cases of unexplained hepatitis have been appearing...
FDA Investigating Reports Of COVID Relapses Following Use Of Pfizer’s Pill Authored by Zachary Stieber via The Epoch Times (emphasis ours), The...
If you can envision a solution that solves a customer's problem, it helps to have technical skills if you want to bring it to market. But...
Cigna Corp. raised the health insurer's annual adjusted profit forecast on May 6, following a decline in COVID-related costs and no sign of pent-up demand...
Zacks Analyst has placed Pfizer Inc. (NYSE: PFE) on the list of the most searched stock. This news is unsurprising as the company has performed well...
With an FDA decision right around the corner, is it time to buy AVDL stock? Keep reading to learn more and what to expect going forward....
The U.S. Food and Drug Administration indirectly refuted Pfizer's recommendation that it's all right for COVID-19 patients to take another round of Paxlovid...
A sudden uptick in demand for HRT may be one reason behind the sudden shortages.
Over time, cancer cells can evolve to become resistant to treatment, more aggressive, and metastatic—capable of spreading to additional sites in the...
A sudden uptick in demand for HRT may be one reason behind the sudden shortages.
A sudden uptick in demand for HRT may be one reason behind the sudden shortages.
Despite the loss of the company's COVID-19 antibody REGEN-COV earlier in 2022, Regeneron posted a positive first quarter driven primarily by sales of...
The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet,...